Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Common Stock | Options Exercise | $0 | +211 | +5.08% | $0.00 | 4.36K | Feb 14, 2022 | Direct | F1 |
transaction | IDXX | Common Stock | Options Exercise | $0 | +210 | +4.81% | $0.00 | 4.57K | Feb 14, 2022 | Direct | |
transaction | IDXX | Common Stock | Options Exercise | $0 | +181 | +3.96% | $0.00 | 4.75K | Feb 14, 2022 | Direct | |
transaction | IDXX | Common Stock | Options Exercise | $0 | +162 | +3.41% | $0.00 | 4.91K | Feb 14, 2022 | Direct | |
transaction | IDXX | Common Stock | Options Exercise | $0 | +87 | +1.77% | $0.00 | 5K | Feb 14, 2022 | Direct | |
transaction | IDXX | Common Stock | Tax liability | -$149K | -295 | -5.9% | $505.53 | 4.71K | Feb 14, 2022 | Direct | |
holding | IDXX | Common Stock | 100 | Feb 14, 2022 | by spouse | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Award | +3.08K | 3.08K | Feb 14, 2022 | Common Stock | 3.08K | $505.53 | Direct | F3, F11 | |||
transaction | IDXX | Incentive Stock Option (right-to-buy) | Award | +197 | 197 | Feb 14, 2022 | Common Stock | 197 | $505.53 | Direct | F4, F11 | |||
transaction | IDXX | Restricted Stock Unit | Award | +371 | +18.5% | 2.38K | Feb 14, 2022 | Common Stock | 371 | Direct | F5, F11 | |||
transaction | IDXX | Restricted Stock Unit | Options Exercise | -211 | -8.88% | 2.17K | Feb 14, 2022 | Common Stock | 211 | Direct | F6, F11 | |||
transaction | IDXX | Restricted Stock Unit | Options Exercise | -210 | -9.7% | 1.96K | Feb 14, 2022 | Common Stock | 210 | Direct | F7, F11 | |||
transaction | IDXX | Restricted Stock Unit | Options Exercise | -181 | -9.26% | 1.77K | Feb 14, 2022 | Common Stock | 181 | Direct | F8, F11 | |||
transaction | IDXX | Restricted Stock Unit | Options Exercise | -162 | -9.13% | 1.61K | Feb 14, 2022 | Common Stock | 162 | Direct | F9, F11 | |||
transaction | IDXX | Restricted Stock Unit | Options Exercise | -87 | -5.4% | 1.53K | Feb 14, 2022 | Common Stock | 87 | Direct | F10, F11 |
Id | Content |
---|---|
F1 | Includes a total of 19 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2021 and December 31, 2021. |
F2 | The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein. |
F3 | Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023. |
F4 | Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. |
F5 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
F6 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2018. |
F7 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. |
F8 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
F9 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
F10 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
F11 | Not applicable. |